Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
![]() |
Fig. 6 d
Puvirajesinghe TM et al. (2016) |
Xla Wt + vangl2 MO
NF13 (RT-PCR) |
|
|||||
![]() |
fig.S1.d
Ossipova O et al. (2015) |
Xla Wt + vangl2 MO
NF18 (immunohistochemistry) |
|
|||||
![]() |
fig.2.f, f^1
Ossipova O et al. (2015) |
Xla Wt + vangl2 MO
NF10.25 (immunohistochemistry) |
|
|||||
![]() |
fig.5..f
Ossipova O et al. (2015) |
Xla Wt + vangl2 MO
NF10.5 (morphology) |
|
|||||
![]() |
fig.s2.g
Ossipova O et al. (2015) |
Xla Wt + vangl2 MO
NF11 (immunohistochemistry) |
|
|||||
![]() |
fig.1.e, f
Ossipova O et al. (2015) |
Xla Wt + vangl2 MO
NF11 (morphology) |
|
|||||
![]() |
fig.5..h
Ossipova O et al. (2015) |
Xla Wt + vangl2 MO
NF11 (morphology) |
|